Countries Australia
Australian Telix Boosts US Presence with IsoTherapeutics Acquisition
Founded in 2005, IsoTherapeutics is a privately held, commercial-stage company, which provides radiochemistry and bioconjugation development and contract m...
February 27, 2024 | News
Enveric Biosciences Divests Cancer-Targeting Cannabinoid IP to Focus on Mental Health Therapeutics
Enveric Biosciences (NASDAQ: ENVB), a pioneering biotechnology firm at the forefront of developing neuroplastogenic small-molecule therapeutics, an...
February 26, 2024 | News
Cure Brain Cancer Foundation CEO Lance Kawaguchi Triumphs in SouthPoleTrek4Cancer, Raising Over $1 Million
Lance Kawaguchi, the dynamic CEO of Cure Brain Cancer Foundation, has achieved an extraordinary milestone by ...
February 26, 2024 | News
Sparsentan Receives CHMP Endorsement for IgA Nephropathy Treatment in Europe
CSL Vifor together with Travere Therapeutics, Inc., disclosed that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CH...
February 26, 2024 | News
AIRS Medical Partners with ParagonCare to Boost SwiftMR™ Sales in Australia and New Zealand
AIRS Medical Inc., a leading provider of AI-powered healthcare solutions, has announced a strategic partnership agreement with ParagonCare Limited&nbs...
February 19, 2024 | News
Biointelect and CR2O Partner to Revolutionize Global Life Science Commercialization
Biointelect and CR2O have announced a strategic partnership aimed at delivering comprehensive commercialization solutions. This collaboration marks a miles...
February 15, 2024 | News
Biocon Biologics Teams Up with Sandoz Australia for Biosimilar Trastuzumab and Bevacizumab
Under the agreement, Sandoz will distribute the Biocon Biologics' brands, OGIVRI® (bTrastuzumab) and ABEVMY® (bBevacizumab), and facilita...
February 09, 2024 | News
Aurora Cannabis Expands Global Footprint with Acquisition of MedReleaf Australia
MedReleaf Australia, holding the coveted #2 spot in the rapidly growing Australian medical cannabis market, was acquired by Aurora in a transaction...
February 09, 2024 | News
Telix to Acquire QSAM Biosciences, Bolstering Bone Cancer Targeting
153Sm-DOTMP utilizes a cutting-edge chelating agent to deliver Samarium-153 radioisotope, offering potential advancements in bone cancer treatment....
February 08, 2024 | News
ShiraTronics finishes Australian pilot study enrollment, gears up for pivotal clinical trial
Migraine, recognized globally as a significant cause of disability, particularly among pre-menopausal women, poses a substantial health challenge. For arou...
February 07, 2024 | News
Stakeholders Rally for Sustainable Funding to Secure Australia's Future of National One Stop Shop for Clinical Trials
The NOSS, a pioneering digital platform, seeks to streamline the approval and reporting procedures for human research, particularly clinical trials, in Aus...
February 06, 2024 | News
Sirius Therapeutics Begins Phase 1 Trial for Long-Acting Factor XI siRNA Anticoagulant
"This study is based on in vivo studies that have demonstrated a nearly 100% reduction in FXI levels for up to 6 months without bleeding events a...
February 04, 2024 | News
Endogenex Receives IDE Approval to Initiate Pivotal Clinical Study
Endogenex, Inc., a clinical stage medical device company dedicated to improving outcomes in patients with Type 2 Diabetes (T2D), announced that the U...
January 31, 2024 | News
Australia's Island Pharma Advances ISLA-101 Study: Third Cohort Successfully Dosed
This achievement follows the recent confirmation from the Data Safety Review Committee that ISLA-101 has been deemed safe and well-tolerated in the 16 subj...
January 23, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
